Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Bouchard

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Neurology|October 1, 1996
Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-IIR G Miller, J P Bouchard, P Duquette, et al.
American Journal of Human Genetics|January 1, 1996
The gene responsible for a severe form of peripheral neuropathy and agenesis of the corpus callosum maps to chromosome 15qL K Casaubon, M Melanson, I Lopes-Cendes, et al.
Annals of Neurology|July 13, 1999
Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the diseaseS C Blumen, B Brais, A D Korczyn, et al.
American Journal of Human Genetics|March 3, 1999
Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11A Richter, J D Rioux, J P Bouchard, et al.
Brain : a Journal of Neurology|May 5, 2006
A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34I Thiffault, M F Rioux, M Tetreault, et al.
Neurology|November 23, 2000
Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 geneS C Blumen, A D Korczyn, H Lavoie, et al.
Nature Genetics|February 2, 2000
ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORFJ C Engert, P Bérubé, J Mercier, et al.
Neurology|August 13, 2008
Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and SwedenP N Valdmanis, E Kabashi, A Dyck, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS studyM S Freedman, G S Francis, E A C M Sanders, et al.
Neurology|September 11, 2009
Mutations in FUS cause FALS and SALS in French and French Canadian populationsV V Belzil, P N Valdmanis, P A Dion, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Neurology|October 1, 1996
Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-IIR G Miller, J P Bouchard, P Duquette, et al.
American Journal of Human Genetics|January 1, 1996
The gene responsible for a severe form of peripheral neuropathy and agenesis of the corpus callosum maps to chromosome 15qL K Casaubon, M Melanson, I Lopes-Cendes, et al.
Annals of Neurology|July 13, 1999
Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the diseaseS C Blumen, B Brais, A D Korczyn, et al.
American Journal of Human Genetics|March 3, 1999
Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11A Richter, J D Rioux, J P Bouchard, et al.
Brain : a Journal of Neurology|May 5, 2006
A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34I Thiffault, M F Rioux, M Tetreault, et al.
Neurology|November 23, 2000
Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 geneS C Blumen, A D Korczyn, H Lavoie, et al.
Nature Genetics|February 2, 2000
ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORFJ C Engert, P Bérubé, J Mercier, et al.
Neurology|August 13, 2008
Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and SwedenP N Valdmanis, E Kabashi, A Dyck, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS studyM S Freedman, G S Francis, E A C M Sanders, et al.
Neurology|September 11, 2009
Mutations in FUS cause FALS and SALS in French and French Canadian populationsV V Belzil, P N Valdmanis, P A Dion, et al.
Pageof 10